chlorambucil has been researched along with dipyridamole in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (57.89) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Rosenberg, MJ; Simon, NM | 1 |
| Blanc, AP; Carcassonne, Y; Gastaut, JA | 1 |
| Gordon, RI; Ratner, MIa; Samokhina, NM; Smirnova, MP; Tomilina, NA | 1 |
| Biriukova, LS; Makurov, AI; Ratner, MIa | 1 |
| Wasserman, LR | 1 |
| Biriukova, LS; Monchakovskiĭ, SF; Ratner, MIa; Tomilina, NA | 1 |
| Davey, F; Goldberg, ME; Moloney, WC; Rodriguez-Erdmann, F | 1 |
| Banfi, G; Imbasciati, E; Ponticelli, C; Tarantino, A | 1 |
| de Croizet, V; Lazcano, F; Passalacqua, W; Plaza de los Reyes, M; Plaza de los Reyes, X; Saffie, A | 1 |
| Donadio, JV | 1 |
| Lakner, V; Ratner, M; Schmitt, E; Sinn, W; Tomilina, N | 1 |
| Biriukova, LS; Fedorova, ND; Makurov, AI; Ratner, MIa | 1 |
3 review(s) available for chlorambucil and dipyridamole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Medical treatment of glomerular diseases.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Azathioprine; Child; Chlorambucil; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Immune Complex Diseases; Immunoglobulin A; Indomethacin; Kidney Glomerulus; Prednisone; Warfarin | 1978 |
Immunosuppressive therapy in primary glomerulonephritis (pros).
Topics: Adrenocorticotropic Hormone; Azathioprine; Chlorambucil; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Heparin; Humans; Immunosuppressive Agents; Indomethacin; Methylprednisolone; Nephrosis, Lipoid; Prednisone; Steroids | 1982 |
1 trial(s) available for chlorambucil and dipyridamole
| Article | Year |
|---|---|
[Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
Topics: Anticoagulants; Azathioprine; Chlorambucil; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerular Filtration Rate; Glomerulonephritis; Heparin; Humans; Immunosuppressive Agents; Prednisone; Warfarin | 1980 |
15 other study(ies) available for chlorambucil and dipyridamole
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Acute leukemia after prolonged immunosuppressive therapy for glomerulonephritis.
Topics: Adolescent; Alkylating Agents; Chlorambucil; Dipyridamole; Glomerulonephritis; Humans; Indomethacin; Leukemia, Myeloid, Acute; Male; Middle Aged | 1978 |
[Treatment of chronic glomerulonephritis].
Topics: Anticoagulants; Chlorambucil; Chronic Disease; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis; Humans; Prednisolone | 1975 |
[Indications and effectiveness of combined therapy in chronic glomerulonephritis].
Topics: Adolescent; Adult; Anticoagulants; Chlorambucil; Chronic Disease; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Male; Middle Aged; Prednisolone | 1987 |
A cooperative study of polycythemia vera.
Topics: Aspirin; Chlorambucil; Dipyridamole; Humans; Leukemia; Polycythemia Vera; Prognosis | 1985 |
[Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
Topics: Adolescent; Adult; Anticoagulants; Cell Division; Chlorambucil; Chronic Disease; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis; Heparin; Humans; Male; Middle Aged; Phenindione; Platelet Aggregation; Prednisolone | 1985 |
Treatment of symptomatic thrombocythemia.
Topics: Busulfan; Chlorambucil; Dipyridamole; Female; Heparin; Humans; Mesenteric Vascular Occlusion; Middle Aged; Thrombocytosis | 1969 |
[Combination therapy with prednisone, chlorambucil, dipyridamole and aspirin in various glomerular diseases. Experience with 33 patients].
Topics: Aspirin; Chlorambucil; Dipyridamole; Drug Therapy, Combination; Humans; Kidney Diseases; Prednisone | 1983 |
Primary glomerular disease: to treat or not to treat.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Kidney Diseases; Kidney Glomerulus; Nephritis; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Warfarin | 1982 |
[The therapy of mesangiocapillary glomerulonephritis].
Topics: Chlorambucil; Chronic Disease; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Heparin; Humans; Phenindione; Prednisolone; Remission Induction; Renal Agents; Time Factors | 1995 |